COSMOS Pharmaceutical Corporation (TYO:3349)

COSMOS Pharmaceutical Revenue

COSMOS Pharmaceutical had revenue of 286.65B JPY in the quarter ending August 31, 2026, with 5.23% growth. This brings the company's total for the last twelve months to 1.11T, up 8.99% year-over-year. In the fiscal year ending May 31, 2026, COSMOS Pharmaceutical had annual revenue of 1.10T with 8.72% growth. That makes COSMOS Pharmaceutical the 1,974th largest company in the world by revenue and 190th in Japan.

• Revenue (ttm): 1.11T
• Revenue Growth: +8.99%
• P/S Ratio: 0.45
• Revenue / Employee: 186.14M
• Employees: 5,984
• Market Cap: 503.28B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2026	1.10T	88.19B	8.72%
May 31, 2025	1.01T	46.40B	4.81%
May 31, 2024	964.99B	137.29B	16.59%
May 31, 2023	827.70B	72.28B	9.57%
May 31, 2022	755.41B	28.99B	3.99%

Data Source: S&P Global Market Intelligence Last updated: Oct 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error